Can systemic inflammation cause a low-T3 pattern with normal TSH and free T4?

Systemic inflammation can profoundly alter thyroid hormone metabolism in peripheral tissues, establishing a distinct low-T3 state without primary thyroid gland dysfunction. This condition, historically termed non-thyroidal illness syndrome (NTIS), occurs even when standard clinical markers like TSH and free T4 remain within normal ranges.

Mechanistic deiodinase alteration

• Pro-inflammatory cytokines, including interleukin-6 (IL-6), tumor necrosis factor-alpha (TNF-alpha), and interleukin-1 beta (IL-1beta), downregulate the transcription and activity of type 1 (D1) and type 2 (D2) deiodinases.
• These same cytokines simultaneously upregulate type 3 deiodinase (D3) activity, shifting the metabolic pathway away from active T3 production toward the generation of inactive metabolites like reverse T3 (rT3).

Oxidative stress and redox regulation

• Cytokine signaling induces intracellular oxidative stress, which directly blocks the enzymatic function of D1 and D2.
• This impairment in peripheral T4-to-T3 conversion is highly dependent on cellular redox status and can be restored or reversed through glutathione replenishment or N-acetyl-cysteine (NAC) administration.

Clinical diagnostic patterns

• Because cytokine-mediated inflammation also blunts the central hypothalamic-pituitary-thyroid (HPT) axis, TSH and free T4 levels often stay within normal or low-normal limits.
• This central blunting, combined with impaired peripheral conversion, produces a functional tissue-level hypothyroid state that is easily missed on routine thyroid panels that do not include free or total T3.

Bottom line

• Systemic inflammation drives a peripheral low-T3 pattern with normal TSH and free T4 by utilizing cytokine signaling (IL-6, TNF-alpha) and oxidative stress to suppress converting deiodinases (D1/D2) and stimulate the inactivating enzyme (D3).